Clinical Trial Update: Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers [Phase 4]

View source ↗

Summary

This Phase 4 trial is evaluating several CAMPs (cellular, acellular, and matrix-like products) plus standard of care versus matched standard of care controls fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Injury
• Pressure Ulcer

Drugs mentioned

• CAMPs (cellular, acellular, and matrix-like products)

Snippet

Sponsor: Tiger Biosciences, LLC. | Conditions: Pressure Ulcer, Ulcer | Phase 4 | Status: RECRUITING